Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology

Charles River and Deciphex: Powered by digital pathology and AI algorithms, Patholytix Foresight drives speed and quality in toxicologic pathology practices April 11, 2024 08:00 AM Eastern Daylight Time WILMINGTON, Mass....

From the Aiosyn blog: In the ever-changing landscape of pathology, the accurate assessment of mitotic activity plays a crucial role in diagnosing and managing various diseases, including cancer. Traditionally, pathologists manually count...

LEHI, UT, April 11, 2024 – Lumea Inc., a forefront innovator in the digital pathology space, is pleased and honored to be announced the winner of Utah’s Best in State award for Medical Innovation. Lumea operates right in the heart of...

Roche (RHHBY) said that it has received CE Mark approval for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx, enabling the identification of metastatic breast cancer patients with low HER2 expression who may benefit from ENHERTU...

PredxBio, Inc., a leader in spatially intelligent biology, and PictorLabs, Inc., a leading digital pathology firm pioneering AI-powered virtual staining technology, are pleased to announce a transformative partnership aimed at...

Lumea: Bringing together Acupath and AIRA Matrix, Lumea leverages its advanced tech to facilitate collaboration in digital pathology. LEHI, UTAH, UNITED STATES, March 25, 2024 /EINPresswire.com/ -- The combined collaboration of these three...